Enhancing the diagnostic accuracy of core needle biopsy in patients with lymphoproliferative disorders by an optimized protocol. [PDF]
Ferrari S +13 more
europepmc +1 more source
Thiopurines and risk of lymphoproliferative disorders. [PDF]
Perananthan V, Sparrow MP, Foley A.
europepmc +1 more source
Correction to "Usefulness of Sarilumab in Patients with Rheumatoid Arthritis after Regression of Lymphoproliferative Disorders". [PDF]
europepmc +1 more source
Lymphoproliferative Disorders Mimicked by Tuberculosis: A Retrospective Study on Lateral Flow Urine Lipoarabinomannan (LF-ULAM) Limitations. [PDF]
McKinnon AE, Spammer YL, Sikhosana SA.
europepmc +1 more source
T Cell Repertoire Analysis as a Molecular Signature of the Spectrum of T-LGL Lymphoproliferative Disorders: Tracing the Literature. [PDF]
Stalika E, Tsamesidis I.
europepmc +1 more source
Ibrutinib pharmacokinetics in B-lymphoproliferative disorders discloses exposure-related incidence of hypertension. [PDF]
Ysebaert L +9 more
europepmc +1 more source
Primary Cutaneous CD30+ Lymphoproliferative Disorders in South Korea: A Nationwide, Multi-Center, Retrospective, Clinical, and Prognostic Study. [PDF]
Lee WJ +26 more
europepmc +1 more source
Correction to: Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders. [PDF]
Palacios-Ortega M +28 more
europepmc +1 more source

